This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated

Copenhagen University Hospital, Rigshospitalet, København Ø

Bispebjerg og Frederiksberg Hospital, København NV

Iatriko Psychikou, Psychikó

Hospital A Coruña, A Coruña

Iatriko of Athens Group/ Iatriko of P. Faliro, P. Faliro

Hospital General Universitario Gregorio Marañón, Madrid

Hospital Puerta de Hierro, Majadahonda

Medizinische Hochschule Hannover, Hanover

HOP Michallon, La Tronche

Hospital Virgen Macarena, Seville

Profil Institut für Stoffwechselforschung GmbH, Neuss

HOP Nord Laënnec, Saint-Herblain

InnoDiab Forschung GmbH, Essen

Univ. Gen. Hosp. of Ioannina, Ioannina

Hospital Clínico de Valencia, Valencia

HOP d'Angers, Angers

University General Hospital of Thessaloniki AHEPA, Thessaloniki

HOP Bichat, Paris

CTC Clinical Trial Consultants AB, Uppsala

Inamed GmbH, Gauting

HOP la Milétrie, Poitiers

City Clinical Hospital named after V.P. Demikhova Department of Health of Moscow, Moscow

"Nonstate Private Healthcare Institution Scientific Clinical Center of LLC Russian Railways", Moscow

Baltic Med,LLC Clinic BaltMed Ozerki, Saint Petersburg

Res.Inst.-Compl.Iss.Cardi.Dis., Kemerovo

Steno Diabetes Center Copenhagen, Gentofte Municipality

Kolding Sygehus, Kolding

Universitätsklinikum Carl Gustav Carus Dresden, Dresden

Hospital Dr. Nélio Mendonça, Funchal

APDP - Associação Protectora dos Diabéticos de Portugal, Lisbon

CHULN, EPE - Hospital de Santa Maria, Lisbon

Hospital Beatriz Ângelo, Loures

Centro Hospitalar Universitário do Porto, EPE - Hospital de Santo António, Porto

D & R s.r.o., Košice

Hospital Vall d'Hebron, Barcelona

Hospital de Bellvitge, L'Hospitalet de Llobregat

CTC Sahlgrenska Universitetssjukhuset, Gothenburg

Sjukhuset, Härnösand, Härnösand

Universitetssjukhuset, Örebro, Örebro

University Hospital of Wales, Cardiff